OBJECTIVES: The aim of this study was to assess the validity of measuring fractional flow reserve (FFR) of the left main (LM) coronary artery in the setting of concomitant left anterior descending (LAD) or left circumflex (LCX) stenoses. BACKGROUND: The theoretical impact of a stenosis in the LAD on the FFR assessment of intermediate LM disease with the pressure wire in an unobstructed LCX is currently unknown. METHODS: A previously validated in vitro model of the coronary circulation was used to create a fixed intermediate stenosis of the LM and a variable downstream LAD or LCX stenosis. The true LM FFR (FFR(LM true)), with no concomitant downstream disease, was compared to the apparent LM FFR (FFR(LM apparent)), with concomitant downstream disease measured with different degrees of LAD or LCX disease. Additionally, an equation based on a resistors model was derived to predict the effect of downstream stenosis on LM FFR (FFR(LM predicted)). RESULTS: In the setting of isolated moderate LM disease (FFR 0.72 ± 0.08), mild to moderate proximal LAD or LCX lesions did not significantly affect LM FFR. Lesions with a composite FFR (LM + downstream disease) ≥0.65 resulted in an FFR(LM apparent) that was not significantly different from FFR(LM true) (0.76 ± 0.06 vs. 0.76 ± 0.05, p = 0.124). Our equation for FFR(LM predicted) accurately modeled the effects of concomitant disease (r = 0.95, p < 0.001). CONCLUSIONS: These data suggest that in the presence of proximal mild to moderate LAD or LCX disease, LM FFR can be reliably measured with the pressure wire placed in the uninvolved epicardial artery.
OBJECTIVES: The aim of this study was to assess the validity of measuring fractional flow reserve (FFR) of the left main (LM) coronary artery in the setting of concomitant left anterior descending (LAD) or left circumflex (LCX) stenoses. BACKGROUND: The theoretical impact of a stenosis in the LAD on the FFR assessment of intermediate LM disease with the pressure wire in an unobstructed LCX is currently unknown. METHODS: A previously validated in vitro model of the coronary circulation was used to create a fixed intermediate stenosis of the LM and a variable downstream LAD or LCX stenosis. The true LM FFR (FFR(LM true)), with no concomitant downstream disease, was compared to the apparent LM FFR (FFR(LM apparent)), with concomitant downstream disease measured with different degrees of LAD or LCX disease. Additionally, an equation based on a resistors model was derived to predict the effect of downstream stenosis on LM FFR (FFR(LM predicted)). RESULTS: In the setting of isolated moderate LM disease (FFR 0.72 ± 0.08), mild to moderate proximal LAD or LCX lesions did not significantly affect LM FFR. Lesions with a composite FFR (LM + downstream disease) ≥0.65 resulted in an FFR(LM apparent) that was not significantly different from FFR(LM true) (0.76 ± 0.06 vs. 0.76 ± 0.05, p = 0.124). Our equation for FFR(LM predicted) accurately modeled the effects of concomitant disease (r = 0.95, p < 0.001). CONCLUSIONS: These data suggest that in the presence of proximal mild to moderate LAD or LCX disease, LM FFR can be reliably measured with the pressure wire placed in the uninvolved epicardial artery.
Authors: Catherine Pagiatakis; Jean-Claude Tardif; Philippe L L'Allier; Rosaire Mongrain Journal: Med Biol Eng Comput Date: 2017-05-13 Impact factor: 2.602
Authors: Bhavik N Modi; Matthew Ryan; Anjalee Chattersingh; Kseniia Eruslanova; Howard Ellis; Nicholas Gaddum; Jack Lee; Brian Clapp; Phil Chowienczyk; Divaka Perera Journal: J Am Heart Assoc Date: 2018-10-16 Impact factor: 5.501
Authors: Katharina A Riedl; Jesper M Jensen; Brian S Ko; Jonathon Leipsic; Erik L Grove; Ole N Mathiassen; Hans Erik Bøtker; Bjarne L Nørgaard Journal: Int J Cardiovasc Imaging Date: 2021-08-12 Impact factor: 2.357